A PDGFβ-specific inhibitor, TKI258, reduces the PDGF-β-induced increase in STAT3 phosphorylation in MiaPaCa2 pancreatic cancer cells and endothelial cells (59). Here, PDGFB is linked to pancreatic neoplasm.